Recommendation ID

Neoadjuvant endocrine therapy in postmenopausal women:- Is there a benefit for neoadjuvant endocrine therapy in postmenopausal women with early breast cancer?

Any explanatory notes
(if applicable)

To find out why the committee made the research recommendation on neoadjuvant endocrine therapy in postmenopausal women, see rationale and impact.

Source guidance details

Comes from guidance
Early and locally advanced breast cancer: diagnosis and management
Date issued
July 2018

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/07/2018